StockNews.com Begins Coverage on NeuroMetrix (NASDAQ:NURO)

StockNews.com assumed coverage on shares of NeuroMetrix (NASDAQ:NURO) in a report issued on Friday. The brokerage set a “sell” rating on the medical device company’s stock.

NeuroMetrix Trading Up 1.8 %

NeuroMetrix stock opened at $4.41 on Friday. The firm has a market capitalization of $8.78 million, a P/E ratio of -0.71 and a beta of 2.26. The stock has a fifty day moving average price of $3.87 and a 200 day moving average price of $3.79. NeuroMetrix has a 52 week low of $2.70 and a 52 week high of $11.55.

NeuroMetrix (NASDAQ:NURO) last released its earnings results on Thursday, February 22nd. The medical device company reported ($1.43) EPS for the quarter. The business had revenue of $1.32 million during the quarter. NeuroMetrix had a negative net margin of 110.64% and a negative return on equity of 31.31%.

Institutional Investors Weigh In On NeuroMetrix

A hedge fund recently bought a new stake in NeuroMetrix stock. Cerity Partners LLC purchased a new stake in shares of NeuroMetrix, Inc. (NASDAQ:NURO) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned 2.80% of NeuroMetrix at the end of the most recent quarter. 19.40% of the stock is owned by hedge funds and other institutional investors.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.